Okta Targets 10% Revenue Growth by FY 2026 with New Strategies

Published 1 days agoOKTA

Okta Targets 10% Revenue Growth by FY 2026 with New Strategies

Okta has announced an ambitious revenue growth target of 9% to 10% for the fiscal year 2026, attributing this to a mix of product innovation and a specialized go-to-market approach. The company has unveiled over 30 new products and features designed to bolster security and enhance customer experiences across its identity clouds.

To achieve these targets, Okta plans to hone its global go-to-market strategy, aiming to align more closely with the identity needs of IT security and developers. This target reflects an expected total revenue of $678 to $680 million for the first quarter of FY 2026, equating to a 10% increase year over year, according to MarketChameleon.com.

Okta's strategy is firmly anchored in improving sales productivity and maintaining a focus on its primary goals: security, growth, and scale. The company aims to continue its leadership in the identity market, with a concerted effort to balance growth and profitability moving forward, as highlighted by recent updates from Investing.com.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Danaher and AstraZeneca Propel AI Advancements in Healthcare

Danaher and AstraZeneca Propel AI Advancements in Healthcare

3 minutes agoDHR

Danaher Corporation and AstraZeneca are spearheading significant advancements in the fields of precision medicine and AI diagnostics, albeit through separate collaborations rather than a joint partnership. Danaher, through its diagnostic and investment arms, teamed up with Innovaccer Inc. in early 2025 to integrate AI into healthcare, aiming to improve patient outcomes via precision diagnostics. This strategic move enhances Danaher's capacity to support value-based care environments effectively. In a separate initiative, AstraZeneca has entered into an $18 million collaboration with Immunai Inc., a company renowned for its AI expertise in the immune system domain. Announced in September 2024, this partnership targets cancer drug trials, utilizing Immunai's AI platform to refine clinical decisions around dose selection and biomarker identification. This collaboration underscores AstraZeneca's commitment to leveraging advanced technology in enhancing the effectiveness of cancer treatments. Both Danaher and AstraZeneca are committed to harnessing AI in healthcare, highlighting separate yet pivotal roles each company plays in the evolution of precision medicine. Despite their parallel endeavors, Reuters reported that there is no current collaboration directly linking these two powerhouses in the healthcare sector.

Gap Inc. Shares Plummet on Tariff Concerns Despite Strong Sales

Gap Inc. Shares Plummet on Tariff Concerns Despite Strong Sales

18 minutes agoGPS

Gap Inc. witnessed a sharp drop in its stock price, falling 15% during after-hours trading, despite surpassing first-quarter sales expectations. This decline reflects investor concerns over the potential financial hit from U.S. tariffs, which could adversely affect the company's gross margins in the upcoming quarter. Reuters highlighted that these concerns emerged even as Gap reported better-than-expected results, driven by strong demand for its Old Navy and namesake brands. The retailer anticipates a financial impact from tariffs amounting to between $250 million and $300 million. However, Gap plans to counteract more than half of these added costs through strategic initiatives, striving to soften the blow on its earnings. For the recent quarter, Gap recorded a 2.2% rise in revenue to $3.46 billion and earnings of 51 cents per share, both figures outperforming analyst projections. Nonetheless, fears over tariffs loom large, with Gap reiterating its fiscal 2025 outlook of 1% to 2% sales growth and 8% to 10% operating income growth, excluding tariff implications. On a positive note, sourcing less than 10% of its merchandise from China could help the company alleviate tariff-related pressures. This strategic supply chain diversification might serve as a buffer against the full brunt of the tariffs, according to analysts cited by TipRanks.

Costco Shows Strong Earnings Despite Consumer Confidence Dip

Costco Shows Strong Earnings Despite Consumer Confidence Dip

33 minutes agoCOST

Costco Wholesale Corporation has delivered impressive financial results in its latest quarter, demonstrating resilience even as consumer confidence wanes. The retailer reported a net income of $5.29 per share, surpassing the expected $5.15 per share, according to Reuters. Overall revenue climbed by 7.5% to $62.15 billion, exceeding analysts' forecasts. Supporting this performance, Costco's same-store sales increased by 5.4%, bolstered by a steady demand in consumables and groceries. When excluding the effects of fuel and currency changes, this figure rises to 9.1%, highlighting strong fundamental growth. As reported by MSM Times, Costco expanded its operations by adding 40 to 50 new locations, bringing its total to 897 warehouses globally. Additionally, the company's membership renewal rates remain robust, with 93% in the U.S. and Canada and 90.5% worldwide as of early March 2025. Costco has successfully captured changes in consumer behavior, with a noted shift from dining out to eating at home enhancing sales in categories like meat and produce, as noted by TheStreet. Such trends align well with Costco's value-centric approach, contributing to ongoing customer loyalty and solid financial performance. As of May 29, 2025, Costco's shares are trading at $1,008.74, reflecting continued investor confidence in the company's strategic positioning and market resilience.

Zscaler Reports Robust Third-Quarter Growth with AI-Driven Advances

Zscaler Reports Robust Third-Quarter Growth with AI-Driven Advances

48 minutes agoZS

Zscaler, Inc. delivered impressive third-quarter results for the fiscal year 2024, showcasing substantial growth and notable strategic initiatives. The company reported a 32% year-over-year increase in revenue, totaling $553.2 million. Additionally, adjusted earnings per share of $0.88 surpassed analyst expectations of $0.65. Zscaler's calculated billings also saw a rise of 30%, reaching $628.0 million in this quarter. These figures underline Zscaler's strong financial performance amidst a growing demand for cybersecurity solutions. In terms of strategic movements, Zscaler made noteworthy acquisitions to bolster its AI capabilities and reinforce its market position. The acquisition of Avalor Technologies in March 2024 aimed to integrate Avalor's Data Fabric for Security with Zscaler's existing data infrastructure. Following this, Zscaler acquired Airgap Networks in April 2024, enhancing its Zero Trust security approach by combining Airgap's agentless segmentation technology with its own offerings. Furthermore, Zscaler announced AI innovations like the ZDX Copilot for IT operations and security insights, alongside launching GenAI App Security to protect AI application usage from data leaks. Recognized for its leadership in the cybersecurity domain, Zscaler was named a Leader in both the Forrester Wave and Gartner Magic Quadrant reports for 2024, highlighting its continued excellence in Security Service Edge solutions. Looking ahead, Zscaler has projected Q4 revenue guidance of $565 million to $567 million and expects full fiscal 2024 revenue between $2.140 billion and $2.142 billion. These strategic and technological advancements, along with market recognition, reflect Zscaler's ongoing commitment to innovation within the cybersecurity landscape.